LAS
VEGAS, Jan. 8, 2025 /PRNewswire/ -- The
Industrial Technology Research Institute (ITRI) initiated its
presence at CES 2025 with an exhibit of 10 wellness and smart
medical technologies. Among the opening highlights, ITRI invited
two-time U.S. badminton Olympian Howard Shu for a live demo of its
AI Badminton Trainer and announced a new partnership
with Singapore-based Reliance Medical Technology (RMT) Group's
subsidiary Reliance Biotech Corporation to commercialize the
iKNOBeads platform for immunotherapy treatments.
An Olympian demonstrates the AI Badminton Trainer
Howard Shu, a two-time U.S.
badminton Olympian and member of the LA2028 Athletes' Commission,
participated in a live demo of ITRI's AI Badminton Trainer,
experiencing the AI-driven solution that enhances players' training
and game performance. Shu said, "It's really cool to see the
machine provide data and output like speed that the human eye
otherwise wouldn't be able to calculate. Without the technology, a
player may be able to tell that they're getting tired at the end of
a match or a third game but wouldn't be able to tell exactly how
much slower their smash may be. Having that data would help a
player who's always looking for the one percent advantage refine
and improve their game. I'm excited to see the introduction and
evolution of this technology for racket sports. Technology, whether
it's for enhancing performance, training or recovery, is helping
players to play longer and smarter."
Partnership with Reliance Biotech Corporation on
iKNOBeads
ITRI announced a partnership between its upcoming spinoff
InnoCell Tech and Reliance Biotech Corporation on promoting the
iKNOBeads platform. The partners will address the growing
international demand for cancer and autoimmune disease treatments
by commercializing the iKNOBeads platform. These magnetic
microbeads are designed to activate immune cells in immunotherapy
treatments.
"We would like to demonstrate ITRI's R&D capacities and
explore new opportunities for collaboration at CES, one of the
world's most influential tech events. This year, we are excited to
announce that ITRI's upcoming spinoff company InnoCell Tech will
collaborate with Reliance Biotech Corporation to launch the
iKNOBeads platform to the global market including the U.S. The
partnership aims to secure a key position in the supply chain and
gain entry into the immunotherapy market," said ITRI President
Edwin Liu.
"The collaboration is a strong partnership, as ITRI excels in
technological capabilities, while RMT Group has long possessed
international resources and market access. This also marks the
first step in tapping into the global market and will benefit more
patients worldwide. The iKNOBeads platform improves the production
efficiency of immune cells and enhances accessibility to cancer
treatment," said Sean Ishihara,
Chairman of RMT Group. "We look forward to the success of this
technology in the U.S., and anticipate that it will be launched in
regions including Asia,
Europe, and the Middle East, becoming a benchmark technology
in the biomedical industry."
ITRI is showcasing 10 innovations in wellness and smart
medical technologies at CES 2025. ITRI invites potential
collaborators for technology transfers and business partnerships.
Interested parties can book a meeting here. ITRI's CES 2025 press
kit is available here. Additional multimedia materials including
technology videos, photos, and fact sheets can be accessed
here.
About ITRI
Industrial Technology Research Institute (ITRI) is one of the
world's leading technology R&D institutions aiming to innovate
a better future for society. Founded in 1973, ITRI has played a
vital role in transforming Taiwan's industries from labor-intensive into
innovation-driven. To address market needs and global trends, it
has launched its 2035 Technology Strategy and Roadmap that focuses
on innovation development in Smart Living, Quality Health,
Sustainable Environment, and Resilient Society.
Over the years, ITRI has been dedicated to incubating startups
and spinoffs, including well-known names such as UMC and TSMC. In
addition to its headquarters in Taiwan, ITRI has branch offices in the U.S.,
Germany, Japan, and Thailand in an effort to extend its R&D
scope and promote international cooperation across the globe. For
more information, please visit https://www.itri.org/eng.
Media contacts
Annie Wu
Office of Marketing Communications, ITRI
+886-3-591-8406
aiyunwu@itri.org.tw
Caroline Kamerschen
Bospar
PRforITRI@bospar.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/itri-opens-ces-2025-with-trend-leading-showcase-and-partnership-with-reliance-biotech-corporation-302346519.html
SOURCE Industrial Technology Research Institute
